How Does Emerging Patent Case Law in the US and Europe Affect Precision Medicine? How Will Today’s Patent Law Affect Tomorrow’s Innovation in the Areas of Biomarkers and Nature-Based Products; Diagnostics; and Algorithms, Big Data and AI?
Aboy, M., Liddell, K., Crespo, C. et al. How does emerging patent case law in the US and Europe affect precision medicine?. Nat Biotechnol 37, 1118–1125 (2019)
Posted: 18 Aug 2020
Date Written: 2019
Precision medicine has stirred the excitement of patients, physicians, industry, entrepreneurs, and investors — it is already a market that is worth tens of billions of dollars with very rapid growth expected. But the future of precision medicine heavily depends on the intellectual property frameworks that apply to its various forms. In order to chart this future, we compare recent patent case law in the US and Europe in three areas of precision medicine:
(1) biomarkers and nature-based products;
(2) diagnostics; and
(3) algorithms, big data, and AI.
We explain how today’s law will affect tomorrow’s innovation.
Suggested Citation: Suggested Citation